What is Akila?
At Akila Labs, we’re using AI and Deep Learning to build a preventative health platform -- focused on diabetes prevention and management.
Akila is interconnected intelligence powered by smart devices, wearables, biosensors, electronic health records, and cloud computing.
Our platform provides patients with a fully digital health coach that is:
- Effective as a personal coach
- Available worldwide
- Affordable, at a fraction of the cost of a human coach
- Personalized, with real-time insights and recommendations
Akila uses A.I. to provide you with personalized cognitive coaching with real time insights and recommendations
Akila is your personal trainer, nutritionist, nurse, counselor, and a personal assistant rolled into one
Akila will help you reverse prediabetes and set you on a path of healthy living and wellness for life.
Lakshmi Anantharamu, PhD
Founder and President
Lakshmi is the founder of Akila Labs, a NYC based startup applying Artificial Intelligence/Machine Learning to create
innovative solutions to solve vexing problems in Healthcare. She’s spearheading the build out of an AI driven and
Blockchain secured Digital Health Coach for Diabetes prevention. She blends her excellent academic and research
background in Computer Science, Algorithm engineering experience with the creative needs of building impactful products.
Lakshmi earned her PhD and MS in Computer Science from the University of Colorado, Denver and has a Bachelors in
Co-Founder and CEO
Prakash Hosalli is an Entrepreneurial leader focused on bringing cutting edge technologies including Blockchain, Artificial
Intelligence, Machine Learning, and Big Data to solve vexing problems in Healthcare. He’s a graduate of National Defence
Academy, Pune India and Indian Military Academy with 8 years of combat experience in the Indian Army as a Paratrooper/Infantry
officer. He has more than 18 years of Technology and Business experience as Program, Project, and Product manager running
large multi-national teams, handling Sales, P&L and Business relationship with marquee clients across US.
Sankar Subramanian, MBA, MHA
Sankar Subramanian, MBA, MHA, CEO is a senior Executive and Director with extensive experience in the Australian healthcare
industry. He has experience in managing hospitals and health insurance companies. He was one of the first entrepreneurs to successfully launch a health/disease
management program in Australia. He received his bachelor’s degree from IIT, Mumbai, an MBA from IIM, Ahmedabad, and an MHA from UNSW,
Australia. He’s the country head and CEO of Akila Labs’ Australian operations.
Elise Brett, Clinical
Dr. Elise Brett is an Associate Clinical Professor - Medicine, Endocrinology, Diabetes and Bone Disease at The
Icahn School of Medicine at Mount Sinai and faculty at Lenox Hill Hospital. She received her B.S. from the
University of Michigan and her M.D. degree from Mount Sinai School of Medicine. Dr. Brett is Endocrine Certified
in Neck Ultrasound and is a Certified Nutrition Support Clinician. She is a member of the American Association of
Clinical Endocrinologists (AACE), the American Society for Parenteral and Enteral Nutrition (ASPEN), the American
Diabetes Association and The Endocrine Society. Dr. Brett with Dr. Jeffrey Mechanick has co-edited and published
various books including, Nutritional Strategies for the Diabetic and Prediabetic Patient, The Complete Guide to
Lifelong Nutrition, and two practical handbooks - Nutritional Medicine Pocket and Diabetes Pocket books.
William Reisacher, Clinical
Dr. Reisacher is an Associate Professor of Otolaryngology - Head and Neck Surgery and Director of Allergy Services
at Weill Cornell Medical College/NewYork-Presbyterian Hospital in NYC. He graduated from Cornell University in
1990 and graduated with Distinction in Research from The Mount Sinai School of Medicine in 1994. Dr. Reisacher
is a Fellow of the American Academy of Otolaryngic Allergy (AAOA), where he has also served on the Board of Directors.
He has been a co-founder, inventor and senior advisor for several early-stage companies in the biotechnology and
digital health-tech spaces.
Raphael Ribeiro, PhD, MBA
Raphael’s expertise in the healthcare/biotech sector resides at the intersection of science, regulatory affairs,
finance and business management. He holds a Ph.D. degree (OHSU; USA), carried out Post-Doctoral training (Duke; USA)
and earned an MBA in Economics and Business Management (FGV; Brazil). He was a scientist and an invited expert for multiple
governmental agencies before moving to the corporate environment. In 2014 he joined the Leste Group as a biotech/pharma
Portfolio Manager in the hedge-fund. He is also responsible for VC and private equity investments in healthcare/biotech/pharma.
In particular, in 2015, he founded and became the CEO of Galileo Biotech, an in-vitro diagnostics company built to explore
a market arbitrage he identified in Latin America.
Mouli Ganguly, Advisory Director Akila Labs, Global and Australia is an International business growth and development
leader. He has successfully launched and led businesses and delivery programs for IBM, EDS, Telstra, BT and smaller tech
companies. He chairs and advises young international growth companies. He received his bachelor’s degree from IIT,
Kharagpur and MBA from IIM, Ahmedabad.